Back
Range Cancer Therapeutics ETF Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.00
Seasonality Move:
2.55%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.55 | Buy |
| 20-day SMA: | 14.53 | Sell |
| 50-day SMA: | 14.82 | Sell |
| 200-day SMA: | 15.04 | Sell |
| 8-day EMA: | 13.77 | Buy |
| 20-day EMA: | 14.27 | Sell |
| 50-day EMA: | 14.62 | Sell |
| 200-day EMA: | 14.55 | Sell |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 40.74 | Sell |
| Chaikin Money Flow: | -17976 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.81 - 15.43) | Sell |
| Bollinger Bands (100): | (14.1 - 15.46) | Sell |
Range Cancer Therapeutics ETF Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 13.79 while CNCR 8-day simple moving average is 13.55, which is a Buy signal.
- The stock price of CNCR is 13.79 while Range Cancer Therapeutics ETF 20-day SMA is 14.53, which makes it a Sell.
- Range Cancer Therapeutics ETF 50-day simple moving average is 14.82 while CNCR share price is 13.79, making it a Sell technically.
- CNCR stock price is 13.79 and Range Cancer Therapeutics ETF 200-day simple moving average is 15.04, creating a Sell signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
49
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a Sell
The current Range Cancer Therapeutics ETF [CNCR] share price is $13.79. The Score for CNCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
13.79
Share Volume:
5.52K
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
10.49
Sell
49
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?
The Range Cancer Therapeutics ETF stock price is 13.79 USD today. -
Will CNCR stock go up or go down?
Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators -
Is Range Cancer Therapeutics ETF overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 13.79 while CNCR 8-day exponential moving average is 13.77, which is a Buy signal.
- The stock price of CNCR is 13.79 while Range Cancer Therapeutics ETF 20-day EMA is 14.27, which makes it a Sell.
- Range Cancer Therapeutics ETF 50-day exponential moving average is 14.62 while CNCR share price is 13.79, making it a Sell technically.
- CNCR stock price is 13.79 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.55, creating a Sell signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
- CNCR Moving Average Covergence Divergence (MACD) indicator is -0.42, suggesting Range Cancer Therapeutics ETF is a Sell
- Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 40.74, which suggest Range Cancer Therapeutics ETF is oversold
- The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (13.81 - 15.43), which suggest Range Cancer Therapeutics ETF is a Sell
- The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (14.1 - 15.46), which suggest Range Cancer Therapeutics ETF is a Sell
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.